INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,936 | -48.1% | 449,706 | +1137.0% | 0.00% | -100.0% |
| Q1 2021 | $337,000 | -54.5% | 36,354 | -56.6% | 0.00% | 0.0% |
| Q4 2020 | $741,000 | -44.5% | 83,717 | -27.3% | 0.00% | -50.0% |
| Q3 2020 | $1,336,000 | -22.8% | 115,201 | +79.4% | 0.00% | -33.3% |
| Q2 2020 | $1,731,000 | +1102.1% | 64,218 | +250.7% | 0.00% | – |
| Q2 2017 | $144,000 | -23.4% | 18,312 | -35.5% | 0.00% | – |
| Q1 2017 | $188,000 | -30.6% | 28,381 | -27.2% | 0.00% | – |
| Q4 2016 | $271,000 | -53.4% | 38,979 | -37.6% | 0.00% | -100.0% |
| Q3 2016 | $582,000 | +561.4% | 62,499 | +480.0% | 0.00% | – |
| Q2 2015 | $88,000 | 0.0% | 10,775 | 0.0% | 0.00% | – |
| Q1 2015 | $88,000 | -83.6% | 10,775 | -81.6% | 0.00% | -100.0% |
| Q4 2014 | $538,000 | -21.9% | 58,601 | -16.2% | 0.00% | -50.0% |
| Q3 2014 | $689,000 | -8.9% | 69,901 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $756,000 | – | 69,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |